Age-associated proteins explain the role of medial temporal lobe networks in Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2024

• Venue

  GeroScience

• Publication date

  2024-07-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11357-024-01291-0PMID 39080151PMCID PMC11979087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies

  2023cited by this paper
• Medial Temporal Lobe Networks in Alzheimer's Disease: Structural and Molecular Vulnerabilities

  2022cited by this paper
• Comparative Analysis of Alzheimer’s Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach

  2022cited by this paper
• Proteomics in aging research: A roadmap to clinical, translational research

  2021cited by this paper
• Genome-wide analysis of common and rare variants via multiple knockoffs at biobank scale, with an application to Alzheimer disease genetics

  2021cited by this paper
• Latent brain state dynamics and cognitive flexibility in older adults.

  2021influential reference
• Identification of plasma proteins relating to brain neurodegeneration and vascular pathology in cognitively normal individuals

  2021cited by this paper
• Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.

  2021cited by this paper
• Temporal phenotyping for transitional disease progress: An application to epilepsy and Alzheimer's disease

  2020cited by this paper
• Longitudinal stability of medial temporal lobe connectivity is associated with tau-related memory decline

  2020influential reference
• Medial temporal lobe connectivity and its associations with cognition in early Alzheimer’s disease

  2020cited by this paper
• Plasma biomarkers of astrocytic and neuronal dysfunction in early‐ and late‐onset Alzheimer's disease

  2019cited by this paper
• Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects

  2019cited by this paper
• The role of brain vasculature in neurodegenerative disorders

  2018cited by this paper
• TETRAD - A TOOLBOX FOR CAUSAL DISCOVERY

  2018cited by this paper
• NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease

  2018cited by this paper
• Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS)

  2017cited by this paper
• Discriminative and Distinct Phenotyping by Constrained Tensor Factorization

  2017cited by this paper
• Federated Tensor Factorization for Computational Phenotyping

  2017cited by this paper
• Cortical thickness is associated with altered autonomic function in cognitively impaired and non‐impaired older adults

  2017cited by this paper
• In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum

  2016cited by this paper
• Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.

  2015cited by this paper
• Insulin-like growth factor-binding protein 7 is up-regulated during EAE and inhibits the differentiation of oligodendrocyte precursor cells.

  2015cited by this paper
• Association between serum haptoglobin and the pathogenesis of Alzheimer's disease.

  2015cited by this paper
• Anterior and posterior MTL networks in aging and MCI.

  2015cited by this paper
• Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings

  2015cited by this paper
• Insulin growth factor binding protein 7 is a novel target to treat dementia.

  2014cited by this paper
• Towards quantitative connectivity analysis: reducing tractography biases

  2014influential reference
• Dementia: Vascular and neurodegenerative pathways—will they meet?

  2013cited by this paper
• Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics.

  2012cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011influential reference
• The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Differential Activation of Tumor Necrosis Factor Receptors Distinguishes between Brains from Alzheimer's Disease and Non-Demented Patients

  2010cited by this paper
• An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

  2006cited by this paper
• The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

  2005cited by this paper
• Measuring the thickness of the human cerebral cortex from magnetic resonance images.

  2000influential reference
• An Algorithm for Fast Recovery of Sparse Causal Graphs

  1991cited by this paper
• Analysis of individual differences in multidimensional scaling via an n-way generalization of “Eckart-Young” decomposition

  1970cited by this paper

• Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline

  2025cites this paper